Slade Dyer

Wolverine signed a Share Purchase Agreement and a potential acquisition target by a major technology company. The company will invest, one-third of the net proceeds received by Dr. Chalk from the sale of Dr. Chalk’s 15% interest in Decision-Zone Inc. (“DZI”), in a private placement of 400,000,000 common shares of Wolverine. Mr. Chalk’s interest inDZI is a potential acquisition target by a major technology company.DZI is the leading developer of next-generation cybersecurity and business efficiency technology. DZI developed and patented dzAudit technology. The patent for dzAudit was issued on March 15, 2011, see link below this commentary. The patent explains that to detect anomalies, current approaches evaluate transaction data statistically and to validate whether the transaction is indeed anomalous requires significant storage, processing power, and human resources.